SFTPD and COVID-19: The level of SP-D was significantly increased in both patients with ARDS and those with fibrosis-like changes on CT scan, suggesting that most patients with ARDS induced by COVID-19 have a higher risk of pulmonary fibrosis compared with patients without ARDS.